Renal hemodynamic dysfunction and neuropathy in longstanding type 1 diabetes: Results from the Canadian study of longevity in type 1 diabetes
Yuliya Lytvyn(University Health Network), David Z.I. Cherney(University Health Network), Michael H. Brent(University of Toronto), Leif Erik Lovblom(Mount Sinai Hospital), Hillary A. Keenan(Joslin Diabetes Center), Petter Bjornstad(University of Colorado Denver), Alanna Weisman(Mount Sinai Hospital), Narinder Paul(University Health Network), Vera Bril(University Health Network), Julie A. Lovshin(Sunnybrook Health Science Centre), Geneviève Boulet(University of Toronto), Mohammed A. Farooqi(Mount Sinai Hospital), Bruce A. Perkins(Sinai Health System), Hongyan Liu(University of Toronto), Rehab B. Albakr(University of Toronto)
Cited by 5
Related Papers
Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials
|The Lancet|2022|1k
State of the Art: Iterative CT Reconstruction Techniques
|Radiology|2015|704
Residual Insulin Production and Pancreatic β-Cell Turnover After 50 Years of Diabetes: Joslin Medalist Study
|Diabetes|2010|497
Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction
|Nature Medicine|2017|493
Sodium Glucose Cotransporter-2 Inhibition in Heart Failure
|Circulation|2017|470